Use of granulocyte-macrophage colony stimulating factor (GM-CSF) in prevention and treatment of fungal infections

European Journal of Cancer

Volumn 35, Issue SUPPL. 3, 1999, Pages 8-10

  Jones, T C ^a  

^a Clinical Research Consultants   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZITHROMYCIN; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3;

ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ANTIGEN PRESENTING CELL; BACTERIAL INFECTION; CANDIDA ALBICANS; CONFERENCE PAPER; CRYPTOCOCCUS NEOFORMANS; HUMAN; IMMUNE RESPONSE; MACROPHAGE; MICROORGANISM; MONOCYTE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; STAPHYLOCOCCUS;

ANIMALS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGES; MYCOSES; OPPORTUNISTIC INFECTIONS;

EID: 0032764323     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00084-2     Document Type: Conference Paper

References (10)

1. Gasson J.C. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood. 77:1991;1131-1145.
2. Gerhartz H.H., Engelhart M., Meusers P.et al. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood. 82:1993;2329-2339.
3. Riikonen P., Saarinen U.M., Makipernaa A.et al. Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of fever and neutropenia: a double-blind placebo controlled study in children with malignancy. Ped. J. Inf. Dis. 13:1994;197-200.
4. Jones T.C. The effect of granulocyte-macrophage colony stimulating factor (rGM-CSF) on macrophage function in microbial disease. Med. Oncol. 13:1996;141-147.
5. Kemper C.A., Bermudez L.E., Deresinski S.C. Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of granulocyte-macrophage colony stimulating factor. J. Inf. Dis. 177:1998;914-920.
6. Schuler G, Romani N. Epidermal Langerhans cells as a model for studying the effects of granulocyte-macrophage colony-stimulating factor and other cytokines on the biology of dendritic cells. In Van Furth ER, ed. Hemopoietic Growth Factors and Mononuclear Phagocytes. Basle, Karger, 1993, 197-204.
7. Lin R., Tarr P.E., Jones T.C. Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases. Clin. Inf. Dis. 21:1995;1439-1449.
8. Bodey G.P., Anaissie E., Gutterman J., Vadhan-Raj S. Role of granulocyte-macrophage colony stimulating factor as adjunct therapy for fungal infection in patients with cancer. Clin. Inf. Dis. 17:1993;705-707.
9. Nemunaitis J., Rabinowe S.N., Singer J.W.et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N. Engl. J. Med. 324:1991;1773-1778.
10. Dierdorf R., Krauter U., Jones T.C A role for granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of neutropenic patients with pneumonia. Brazil J. Inf. Dis. 1:1997;68-76.